PremiumThe FlyTheriva Biologics downgraded to Hold from Buy at Maxim Theriva Biologics downgraded to Hold from Buy at Maxim Theriva Biologics prices 6.8M shares at $1.10 in public offering PremiumCompany AnnouncementsTheriva Biologics Reports 2024 Financial Results and Progress Theriva Biologics files to sell 7.69M shares of common stock, warrants Theriva Biologics Advances VCN-01 with FDA Guidance PremiumMarket News3 Penny Stocks to Watch Now, 11/5/24 Theriva Biologics Expands Stock Plans and Share Authority Theriva Biologics picked as finalist in competition for Merck KGaA’s EMEA grant